cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer

Published:2014 Issue:9 Volume:5 Page:745-753
ISSN:1837-9664
Container-title:Journal of Cancer
language:en
Short-container-title:J. Cancer

Author:

Sohn Joohyuk,Liu Shuying,Parinyanitikul Napa,Lee Jangsoon,Hortobagyi Gabriel N.,Mills Gordon B.,Ueno Naoto T.,Gonzalez-Angulo Ana M.

Publisher

Ivyspring International Publisher

Subject

Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy;Phytomedicine;2024-06

2. Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors;Frontiers in Immunology;2024-03-06

3. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR;Journal of Experimental & Clinical Cancer Research;2023-11-04

4. Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13;Proceedings of the National Academy of Sciences;2023-09-11

5. The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations;Molecular Cancer Therapeutics;2023-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP